-+ 0.00%
-+ 0.00%
-+ 0.00%

SPYRE ANNOUNCES POTENTIAL BEST-IN-CLASS SPY003 (ANTI-IL-23) PART A INDUCTION RESULTS FROM SKYLINE TRIAL, COMPLETING PROOF-OF-CONCEPT FOR ALL THREE COMPONENTS OF ITS IBD COMBINATIONS

Reuters·09/08/2026 12:00:08

Please log in to view news